The transaction includes $70m in cash and a $20m retained equity position for Nektar in a new Ampersand portfolio company.

After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...

(RTTNews) - Nektar Therapeutics (NKTR), Monday announced a decision to sell its Alabama-based commercial-scale manufacturing facility and PEGylation reagent supply business to Ampersand Capital ...

Therapeutics announced that it has entered into a definitive agreement to sell its Huntsville, Alabama manufacturing facility and ...

Huntsville-based facility to be spun out as standalone Ampersand portfolio company. Nektar to receive $90 million in tota ...

Nicolle Pangis, a former head of the cable-ad-sales entity Ampersand, has joined Netflix as is vice president of ad sales ...

Netflix has named Nicolle Pangis as its new VP of advertising, TheWrap has learned. Pangis, who most recently served as CEO ...

Bioanalytical contract research organization Resolian has announced significant leadership changes as it continues its global expansion. Rob Stachlewitz has been named the new Chief Executive Officer, ...

Nicolle Pangis, formerly CEO of Ampersand, will bring a data-driven approach to the streamer as it continues to scale its ...

BOSTON, Oct. 31, 2024 /PRNewswire/ -- For the third consecutive year, Ampersand Capital Partners has been named to Inc.'s 2024 Founder-Friendly Investors list, which honors the private equity and ...

Ampersand Biosciences and Trudeau Institute have been awarded more than $1 million to study infectious diseases.

Pangis, most recently CEO of advanced TV firm Ampersand, will oversee the U.S. and Canada ads business for the streaming giant.